NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $1.09 +0.08 (+7.92%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.07 -0.02 (-1.83%) As of 03/25/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Milestone Scientific Stock (NYSE:MLSS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Milestone Scientific alerts:Sign Up Key Stats Today's Range$1.01▼$1.0950-Day Range$0.91▼$1.3352-Week Range$0.54▼$1.39Volume126,610 shsAverage Volume136,532 shsMarket Capitalization$84.90 millionP/E RatioN/ADividend YieldN/APrice Target$1.25Consensus RatingBuy Company OverviewMilestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Read More… Remove Ads Milestone Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreMLSS MarketRank™: Milestone Scientific scored higher than 17% of companies evaluated by MarketBeat, and ranked 876th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingMilestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMilestone Scientific has received no research coverage in the past 90 days.Read more about Milestone Scientific's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Milestone Scientific is -15.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Milestone Scientific is -15.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMilestone Scientific has a P/B Ratio of 9.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for MLSS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMilestone Scientific does not currently pay a dividend.Dividend GrowthMilestone Scientific does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for MLSS. News and Social Media1.4 / 5News SentimentN/A News SentimentMilestone Scientific has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Milestone Scientific this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Milestone Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders24.75% of the stock of Milestone Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.79% of the stock of Milestone Scientific is held by institutions.Read more about Milestone Scientific's insider trading history. Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address MLSS Stock News HeadlinesMilestone Scientific announces CompuFlo rollout at Pain Doctors MedicalFebruary 4, 2025 | markets.businessinsider.comMilestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLCFebruary 4, 2025 | globenewswire.comTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.March 26, 2025 | Porter & Company (Ad)Milestone Scientific announces CompuFlo rollout at Advanced Spine and PainJanuary 24, 2025 | markets.businessinsider.comMilestone Scientific rolls out new epidural systemJanuary 24, 2025 | msn.comMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder DhillonJanuary 23, 2025 | globenewswire.comMLSS stock touches 52-week high at $1.28 amid robust annual gainsJanuary 21, 2025 | msn.comMilestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024December 4, 2024 | globenewswire.comSee More Headlines MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed this year? Milestone Scientific's stock was trading at $0.96 at the beginning of the year. Since then, MLSS stock has increased by 13.5% and is now trading at $1.09. View the best growth stocks for 2025 here. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) announced its quarterly earnings data on Thursday, August, 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The firm had revenue of $1.85 million for the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%. Who are Milestone Scientific's major shareholders? Milestone Scientific's top institutional shareholders include Bridgeway Capital Management LLC (0.47%), Carnegie Investment Counsel (0.22%), Renaissance Technologies LLC (0.16%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard. View institutional ownership trends. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/15/2024Today3/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:MLSS CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees30Year FoundedN/APrice Target and Rating Average Stock Price Target$1.25 High Stock Price Target$1.25 Low Stock Price Target$1.25 Potential Upside/Downside+14.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,930,000.00 Net Margins-52.01% Pretax Margin-52.21% Return on Equity-60.26% Return on Assets-40.23% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio1.86 Sales & Book Value Annual Sales$8.88 million Price / Sales9.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book9.91Miscellaneous Outstanding Shares77,892,000Free Float58,614,000Market Cap$84.90 million OptionableOptionable Beta1.41 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:MLSS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.